SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 is a research paper published in Cell (2020). On theSindex it has a DataRank of 11.0. It has been cited 1,206 times, with 200 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.1
From this paper's citation signal
Citation Network Contribution
9.9
From 200 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 200 citers.
U.S. Department of Defense
Grant: W81XWH-20-1-0270
U.S. Department of Defense
Grant: Fluomics/NOSI U19 AI135972
Danmarks Grundforskningsfond
Grant: AI007245
Danmarks Grundforskningsfond
Grant: GM007753
Alfred Benzon Foundation
Grant: R01 AI146779
National Heart, Lung, and Blood Institute
Grant: P01 HL131474
National Science Foundation
Grant: 2031989
RAPID: Glycan coreceptors for SARS-CoV-2 spike protein
Bill and Melinda Gates Foundation
Grant: OPP1170236
Bill and Melinda Gates Foundation
Grant: DNRF107
NHLBI NIH HHS
Grant: P01 HL107150
NIGMS NIH HHS
Grant: R01 GM128464
NIDDK NIH HHS
Grant: T32 DK007044
NHLBI NIH HHS
Grant: K12 HL141956
NIGMS NIH HHS
Grant: T32 GM008313
NIAID NIH HHS
Grant: U19 AI135972
NIAID NIH HHS
Grant: T32 AI007245
NICHD NIH HHS
Grant: DP2 HD087954
NIGMS NIH HHS
Grant: T32 GM007753
National Institutes of Health
Grant: 5P01HL131474-03
Protein Glycosylation in the Coagulopathy and Inflammation of Sepsis
National Institutes of Health
Grant: 3R01AI146779-01S1
Epitope focusing to the receptor binding motif for a universal coronavirus vaccine
National Institutes of Health
Grant: 5U19AI135972-04
Fluomics: The Next Generation
National Science Foundation
National Heart, Lung, and Blood Institute
FWCI
21.13
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Methylprednisolone, venous thromboembolism, and association with heparin to 30 days in hospital survival in severe Covid-19 pneumonia
Additional file 1 of Methylprednisolone, venous thromboembolism, and association with heparin to 30 days in hospital survival in severe Covid-19 pneumonia
Additional file 1 of Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
Additional file 1 of Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
Additional file 1 of Recombinant human plasma gelsolin reverses increased permeability of the blood–brain barrier induced by the spike protein of the SARS-CoV-2 virus
Additional file 1 of Recombinant human plasma gelsolin reverses increased permeability of the blood–brain barrier induced by the spike protein of the SARS-CoV-2 virus
Additional file 1 of ApoE4 associated with severe COVID-19 outcomes via downregulation of ACE2 and imbalanced RAS pathway
Additional file 1 of ApoE4 associated with severe COVID-19 outcomes via downregulation of ACE2 and imbalanced RAS pathway
Additional file 3 of Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19
Additional file 3 of Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19
Additional file 1 of The mutation of Japanese encephalitis virus envelope protein residue 389 attenuates viral neuroinvasiveness
Additional file 1 of The mutation of Japanese encephalitis virus envelope protein residue 389 attenuates viral neuroinvasiveness
Additional file 3 of Tilorone mitigates the propagation of α-synucleinopathy in a midbrain-like organoid model
Additional file 3 of Tilorone mitigates the propagation of α-synucleinopathy in a midbrain-like organoid model
Additional file 1 of Tilorone mitigates the propagation of α-synucleinopathy in a midbrain-like organoid model
Additional file 2 of Tilorone mitigates the propagation of α-synucleinopathy in a midbrain-like organoid model
Additional file 1 of Tilorone mitigates the propagation of α-synucleinopathy in a midbrain-like organoid model
Additional file 2 of Tilorone mitigates the propagation of α-synucleinopathy in a midbrain-like organoid model
Additional file 4 of Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19
Additional file 4 of Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19